Conditioning regimens
| . | Number . |
|---|---|
| Reduced-intensity regimen | |
| TBI + cyclophosphamide + fludarabine | 7 |
| TBI + other chemotherapeutic agents | 4 |
| Busulfan + fludarabine | 8 |
| Melphalan + fludarabine | 13 |
| Cyclophosphamide + fludarabine | 4 |
| Cyclophosphamide + melphalan | 2 |
| Cyclophosphamide + etopside | 1 |
| Myeloablative regimen | |
| TBI + cyclophosphamide | 63 |
| TBI + other chemotherapeutic agents | 8 |
| Busulfan + cyclophosphamide | 58 |
| Busulfan + melphalan | 6 |
| Busulfan + fludarabine | 6 |
| . | Number . |
|---|---|
| Reduced-intensity regimen | |
| TBI + cyclophosphamide + fludarabine | 7 |
| TBI + other chemotherapeutic agents | 4 |
| Busulfan + fludarabine | 8 |
| Melphalan + fludarabine | 13 |
| Cyclophosphamide + fludarabine | 4 |
| Cyclophosphamide + melphalan | 2 |
| Cyclophosphamide + etopside | 1 |
| Myeloablative regimen | |
| TBI + cyclophosphamide | 63 |
| TBI + other chemotherapeutic agents | 8 |
| Busulfan + cyclophosphamide | 58 |
| Busulfan + melphalan | 6 |
| Busulfan + fludarabine | 6 |